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Background: Cellular angiofibroma is a rare benign mesenchymal neoplasm with morphological and
immunohistochemical similarities to spindle cell lipoma. Karyotypic information on cellular angiofibroma
is restricted to one case only which showed loss of material from chromosomes 13 and 16. A few other
studies using fluorescence in situ hybridization showed deletions of the RB1 and FOXO1 loci, both of which
are located in chromosome band 13q14. We present here cytogenetic data on two cellular angiofibromas
with an abnormal karyotype.
Methods: G-banding and fluorescence in situ hybridization (FISH) analyses were done on two cellular angiofibromas.
Results: In both tumors, a rearrangement leading to loss of chromosome 13 material was seen, together with other
structural chromosome abnormalities. FISH analysis showed heterozygous deletion of the RB1 locus (13q14) in both cases.
Conclusion: Our results demonstrate loss of chromosome 13 material in cellular angiofibroma, though not as the sole
cytogenetic change, confirming the (cyto)genetic similarity of these tumors with spindle cell lipomas.
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Cellular angiofibroma is a rare benign mesenchymal
neoplasm, first described by Nucci et al. in 1997 in a
series of 6 cases that occurred almost exclusively in the
vulva of middle-aged women [1]. A few months later,
Laskin et al. described 11 histologically similar lesions
named “angiomyofibroblastoma-like” tumor, found in
the inguinoscrotal area of adult men [2]. Because there
were no reproducible morphologic differences between
the tumors in females and males, the World Health
Organization classification adopted the term “cellular
angiofibroma” for this neoplasm in both genders [3].
Although cellular angiofibromas are usually found in the
superficial soft tissues of the vulva and inguinoscrotal or
paratesticular regions [3], the tumor has also been seen* Correspondence: ioannis.panagopoulos@rr-research.no
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spine, oral mucosa, knee, upper eyelid, hip, chest wall,
axilla, and hypocondrium ([3, 4] and references therein).
The etiology is unknown, but expression by tumor cells
of estrogen and progesterone receptor suggests that
these hormones play a role in tumorigenesis [3]. Cellular
angiofibromas display adipose and myofibroblastic dif-
ferentiation under the influence of hormones, microen-
vironments, cytokines, and growth factors [1, 2, 5, 6].
The tumors are smaller in women than in men [3],
generally well circumscribed, and characterized by two
main components: bland spindle cells and small to
medium-sized vessels with mural hyalinization [1, 7, 8].
Cytogenetic information about cellular angifibroma is
restricted to one case only [9] which by G-banding and
fluorescence in situ hybridization (FISH) analyses was
found to have the karyotype 45,XY,add(2)(q33),add(12)
(p11.2),-13[3]/44,idem,-16[2].ish add(2)(wcp13-),add(12)
(wcp13+,LSI 13q14-,LSI 13q34+),der(16)(wcp13+)[3]. Be-
cause cellular angiofibroma shares morphological andle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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and because monosomy for chromosomes 13 and 16 and
unbalanced rearrangements of 13q and 16q are the most
frequent aberrations in spindle cell lipomas, the authors
suggested that cellular angiofibroma is genetically similar
to spindle cell lipoma [9]. In subsequent studies, deletions
of the RB1 and FOXO1 loci, located in chromosome band
13q14, were found by interphase FISH [7, 10–12].
We present here the cytogenetic data on two cases of cel-
lular angiofibroma. Our results show consistent involvement
of chromosome 13 in these tumors with loss of 13q, under-
scoring the suggested (cyto)genetic similarity between cellu-
lar angiofibroma and spindle cell lipomas.
Methods
Patients
Data concerning patients’ gender and age, tumor loca-
tion, depth, size, and immunostaining are shown in
Table 1. Figure 1 shows the pathologic examination of
the cellular angiofibroma of case 2. It includes a macro-
scopic picture (Fig. 1a), hematoxylin and eosin (HE)
staining (Fig. 1b and c), and immunoexpression of CD34
(Fig. 1d). The pathologic findings were similar in case 1.
Microscopic examination of the lesions showed well de-
marcated tumors of spindle cells without atypia with
small oval nuclei. In the background, there was a collag-
enous stroma with many vessels with dilated lumina of
different sizes and groups of mature fatty cells. CD34
was positive at immunohistochemical analysis. The
morphology was typical for a classical cellular
angiofibroma.
G-banding, Karyotyping, and FISH
Fresh tissue from a representative area of the tumors
was received and analyzed cytogenetically as part of our
diagnostic service. The samples were disaggregated
mechanically and enzymatically with collagenase II
(Worthington, Freehold, NJ, USA). The resulting cells
were cultured and harvested using standard techniques.
Chromosome preparations were G-banded with Wright's
stain (Sigma-Aldrich; St Louis, MO, USA) andTable 1 Clinicopathological and cytogenetic data on the cellular an
Cases Sex/Age Site Depth Largest diameter (cm) Imm




2 M/79 Scrotum Subcutaneous 7 CD34
S100
ER Fo
PGRexamined. Metaphases were analyzed and karyograms
prepared using the CytoVision computer assisted karyo-
typing system (Leica Biosystems, Newcastle, UK). The
karyotypes were described according to the International
System for Human Cytogenetics Nomenclature [13].
Interphase and metaphase FISH analyses were per-
formed for both cases. The RB1 deletion probe, pur-
chased from Cytocell (http://www.cytocell.co.uk), was
used in order to detect deletion of the RB1 locus in
13q14.2. It consists of a 318 kb red probe spanning the
RB1 gene and a 13qter green probe acting as a control
for chromosome 13. Fluorescent signals were captured




Both cellular angiofibromas had abnormal karyotypes
that entailed heterozygous loss of material from the long
arm of chromosome 13 (Table 1, Fig. 2), together with
other chromosome aberrations (Table 1). In case 1, there
was an unbalanced translocation between chromosomes
1 and 13 described as der(13)t(1;13)(q12 ~ 21;q14 ~ 21)
accompanied by monosomy 14 and aberrations of
chromosome 16 (Table 1, Fig. 2a and b). FISH analysis
in case 1 showed deletion of the RB1 probe in 111 out
of 200 investigated interphase nuclei (Fig. 2c). In case 2,
an interstitial deletion in chromosome 13 was found
which was described as del(13)(q12q22) together with a
balanced t(10;15)(p13;q22) (Table 1, Fig. 2d). FISH ana-
lysis of metaphase spreads showed that the RB1 probe
was heterozygously deleted also in case 2 (Fig. 2e and f).
Discussion
The present study shows consistent heterozygous loss of
material from chromosome arm 13q in two cellular
angiofibromas, supporting the observation first put for-
ward by Hameed et al. [9] that these tumors are (cyto)-
genetically similar to spindle cell lipomas. The examined
tumors arose in the inguinoscrotal or paratesticular











Fig. 1 Pathologic examination of the cellular angiofibroma in case 2. a Macroscopic picture of the tumor. b Low power HE-stained slide showing
well circumscribed tumor with adipocytic components. c High power HE-stained slide showing spindle cells with admixed adipose tissue and
blood vessels. d Immunohistochemical analysis demonstrating positivity for CD34
Fig. 2 G-banding and FISH information on two cellular angiofibromas. a-c: Case 1, d-f: Case 2. a Partial karyotype of case 1 showing the two normal copies
of chromosome 1, a normal chromosome 13, and the der(13)t(1;13)(q12 ~ 21;q14 ~ 21). b Partial karyotype showing the normal chromosome 16 and the
der(16)t(7;16)(q11;q22). c Interphase FISH showing one red signal (probe for the RB1 gene) and one green signal (probe for 13qter) in three interphase nuclei
and two red and two green signals in one nucleus. d Partial karyotype of case 2 showing the normal chromosome 13 and the del(13)(q12q22). e G-banding
of a metaphase spread used for FISH analysis. f FISH results with the RB1 deletion probe consisting of a 318 kb red probe spanning the RB1 gene locus and a
13qter green probe acting as a control for chromosome 13. The RB1 locus was deleted in the del(13)(q12q22). Breakpoint positions are indicated by arrows
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material from chromosome 13 was accompanied by
other chromosome aberrations (Table 1). Also the only
hitherto karyotyped cellular angiofibroma had loss of
chromosome 13 together with additional chromosome
aberrations [9]. Although the analyzed G-banded cases
number only three, two of which are described here
(Table 1), the data show that loss of 13q material is not
(usually) the only cytogenetic anomaly in tumors of this
type (Table 1, [9]). This, too, strengthens the cytogenetic
similarity with spindle cell lipomas: Most of the 28
karyotypically abnormal spindle cell lipomas reported in
the cytogenetic literature had loss of material from 13q
together with other chromosome abnormalities, most
often loss of or from 16q (http://cgap.nci.nih.gov/
Chromosomes/Mitelman, Database last updated on
August 11, 2016). Our analysis further showed that the
structural aberrations affected bands 13q14~21 or
13q12-q22 which are also the most commonly lost in
spindle cell lipomas [14–16]. The deletion of the RB1
locus, found by FISH, adds evidence pointing in the
same direction [7, 9, 11, 12]. Maggiani et al. [11] exam-
ined by interphase FISH two cellular angiofibromas. The
first tumor had a deletion of 13q14 that included the
RB1 and FOXO1 loci. In the second tumor, the deleted
region contained FOXO1 but not RB1 [11].
Studies of spindle cell lipomas using FISH and single
nucleotide polymorphism (SNP) array methodologies
have identified two minimal deleted regions (MDR) in
13q14 [14, 15]. In MDR1, four genes are located, includ-
ing the tumor suppressor gene RB1. In MDR2, there are
34 gene loci as well as the two microRNA genes
miR-15a and miR-16-1 [14]. Because the expression
levels of RB1 were not significantly reduced and because
no mutations were seen by sequencing, the authors con-
cluded that there is no decisive support for RB1 as the
main target for the 13q deletions in spindle cell lipomas
[14]. Instead, their data implicate miR-16-1 as a potential
target for the 13q deletions in these tumors [14]. On the
other hand, immunohistochemical staining for RB1
showed that nuclear RB1 expression was deficient in all
examined spindle cell lipomas, pleomorphic lipomas,
and cellular angiofibromas, as well as in 17 of 19 (89%)
mammary-type myofibroblastomas [10]. At the moment,
one cannot say more than that the molecular target of
chromosome 13 aberrations in cellular angiofibromas
remains unknown.
Although cellular angiofibroma overlaps morphologic-
ally with spindle cell lipoma and mammary-like myofibro-
blastoma, the three tumors also have some distinctive
morphological features. In cellular angiofibroma, spindle-
shaped cellularity is prominent as are hyalinized blood
vessels and only minimal adipose tissue. Similarly, thick-
walled blood vessels are not seen in the other two entities.In spindle cell lipomas, a mixture of mature adipocytes
and bland spindle cells are found against a mucinous,
myxoid, or fibrous background. In mammary-type myofi-
broblastoma, finally, fascicles of spindle cells with features
of myofibroblasts are seen, with intervening hyalinized
collagenous stroma together with various amounts of adi-
pose tissue ([11, 12, 17] and references therein). The mor-
phologic similarities of these tumors together with their
cytogenetic similarities, in particular loss of material from
the long arm of chromosome 13, suggest that they arise
through largely identical pathogenetic mechanisms from a
common stromal precursor cell which then undergoes
(myo)fibroblastic or adipocyte differentiation [11, 17].
Conclusions
Our results show consistent involvement of chromo-
some 13 in cellular angiofibromas with loss of 13q,
underscoring the suggested (cyto)genetic similarity be-
tween cellular angiofibroma and spindle cell lipomas.
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